Taken together, these results suggest that FEN mediated inhibition of DES1 protein and thus inhibition of excess ceramide biosynthesis and lipotoxicity may be part of the mechanism of preventing insulin resistance and NAFLD/NASH. This evidence concerns the gene DEGS1 and metabolic dysfunction-associated steatotic liver disease.